Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-143-5 | CAS number: 80675-49-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- Version April 24, 2002
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- Version March 2003
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-[(1E)-2-(2-methoxy-5-nitrophenyl)diazen-1-yl]-N-(2-methoxyphenyl)-3-oxobutanamide
- EC Number:
- 617-143-5
- Cas Number:
- 80675-49-6
- Molecular formula:
- C18H18N4O6
- IUPAC Name:
- 2-[(1E)-2-(2-methoxy-5-nitrophenyl)diazen-1-yl]-N-(2-methoxyphenyl)-3-oxobutanamide
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Identifier: CAS 80675-49-6
- Lot/batch No.: L-7015-20
- Yellow powder
- Storage conditions: Ambient temperature, no protection from light necessary
Constituent 1
- Specific details on test material used for the study:
- - Identifier: CAS 80675-49-6
- Lot/batch No.: L-7015-20
- Analytical purity: 95%
- Yellow powder
- Storage conditions: Ambient temperature, no protection from light necessary
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: CBA/J mouse from Charles River Laboratories, Research Models and Services, Germany GmbH, 97633 Sulzfeld, Germany
- Weight at study initiation: 18.2 g – 21.3 g
- Housing: single housed in Makrolon cages, type II
- Diet: ad libitum, Kliba-Labordiaet (Maus / Ratte Haltung “GLP”), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland
- Water: ad libitum, tap water
- Acclimation period: 7 days before the first application of the test substance.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12 (6.00 p.m. – 6.00 a.m. / 6.00 a.m. – 6.00 p.m.)
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Remarks:
- Used as vehicle because a good homogeneity of the preparation could be achieved.
- Concentration:
- 30 % preparation (maximum technically applicable concentration); 25 μL test substance suspension in vehicle per ear
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS: not conducted
- Compound solubility: the homogeneity of the test substance preparation during application was provided by stirring with a high speed homogenizer and/or a magnetic stirrer.
- The homogeneity of the test substance preparation was investigated once by analysis during the study.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay
- Criteria used to consider a positive response:
The parameters used to characterize the response are:
(1) Lymph node cell count,
(2) [3]H-thymidine incorporation into the lymph node cells,
(3) And to a certain extent lymph node weight.
(4) Because not only sensitization induction but also irritation of the ear skin by the test substance may induce lymph node responses, the weight of ear punches taken from the area of test-substance application is determined as a parameter for inflammatory ear swelling serving as an indicator for the irritant action of the test substance.
(5) The increase SI of cell count by a factor of ≥ 1.5 and/or of 3H-thymidine incorporation by a factor of ≥ 3 as compared to the concurrent vehicle control group is generally considered as indicating a sensitizing potential of a test substance.
(6) If applicable, the estimated concentration (EC) leading to the respective SI values were calculated by linear or semi-logarithmical regression between the data points directly below and above the SI if possible or using the two nearest points below or above the SI.
(7) In addition the evaluation uses the following considerations:
(a) If biologically relevant increases in ear weights are running in parallel to the increase in cell count, [3]H-thymidine incorporation and/or lymph node weight, it cannot be ruled out, that the lymph node response was caused by irritation and not by skin sensitization. Depending on the magnitude of lymph node response the evaluation of the sensitizing potential may be modified or additional studies might be necessary by expert judgment.
(b) If a test substance does not elicit a biological relevant increase in cell count, 3H-thymidine incorporation but shows a clear concentration related increase in response, further investigation of the sensitization potential at higher concentrations should be considered.
TREATMENT PREPARATION AND ADMINISTRATION:
The animals of negative control (group 1) and test (group 2) groups were treated with vehicle or test-substance
1) Treatment
- Site of application: dorsal part of both ears
- Frequency of application: 3 consecutive applications (day 0 – day 2) to the same application site
- Mortality: twice each workday (beginning and end) and once on Saturdays, Sundays and on public holidays.
2) [3]H-thymidine injection
On study day five (about 66 to 72 hours after the last application of test substance to the ears) the mice were injected intravenously with 20 μCi of 3H-thymidine in 250 μL of sterile saline into a tail vein.
3) Terminal procedures
The animals were sacrificed on study day 5 about 5 hours after [3]H-thymidine injection by cervical dislocation.
- Determination of ear weight: to detect a potential inflammatory ear swelling a circular piece of tissue (diameter 0.8 cm) was punched out of the apical part of each ear of all animals immediately after the death of each animal. The weight of the pooled punches was determined for each test group.
- Removal and weight determination of the lymph nodes: immediately after removal of the ear punches the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal.
- Preparation of cell suspension and determination of cell count: after weight determination, the pooled lymph nodes of each test group were stored in phosphate buffered saline (PBS) in ice water bath until further preparation. A single cell suspension was prepared as soon as possible after dissection by carefully passing all lymph nodes per test group through an iron mesh (mesh size 200 μm) into 40 mL of PBS. For determination of cell counts, an aliquot of each suspension was further diluted with Casy®ton in a ratio 1:500. The cell count was determined using a Casy®-Counter.
- Measurement of [3]H-thymidine incorporation of the lymph node cells: the remaining cell suspensions were washed twice with PBS and precipitated with 5 % trichloroacetic acid (TCA). Each precipitate was transferred to scintillation fluid and incorporation of [3]H-thymidine into the cells was measured in a ß-scintillation counter. - Positive control substance(s):
- other: studies using Alpha-Hexylcinnamaldehyde are performed twice a year in the laboratory
- Statistics:
- The stimulation indices of cell count, [3]H-thymidine incorporation, lymph node weight and ear weight were calculated as the ratio of the test group values for these parameters divided by those of the vehicle control group.
Results and discussion
- Positive control results:
- The result of the historical positive control tests show that the test system is able to detect sensitizing compounds under the test conditions chosen.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Remarks:
- auricular lymph node cell counts
- Value:
- 1.31
- Test group / Remarks:
- cut off value: 1.5
- Key result
- Parameter:
- SI
- Remarks:
- [3]H-thymidine incorporation
- Value:
- 2.33
- Test group / Remarks:
- cut off stimulation index: 3
Any other information on results incl. tables
Ear weight:
The test substance (TS) preparation caused some increase in ear weights indicating an ear skin irritation. The ears of all animals showed a yellow discoloration on study days 1 and 2 and on the day of lymph node removal.
Lymph node weight:
no relevant increase was observed.
Body weights:
The expected body weight gain was generally observed in the course of the study.
Other findings:
No abnormalities were observed during general observation. No signs of systemical toxicity were observed.
Table 1: Cell count, [3]H-thymidine incorporation and lymph node weight: test group mean values and stimulation indices
Test group |
Treatment |
Cell counts |
|
[Counts/Lymph Node Pair] |
Stimulation Index(a) |
||
1 |
Vehicle propylene glycol |
7385333 |
1.00 |
2 |
30 % TS in propylene glycol |
9642667 |
1.31 |
|
[3]H-thymidine incorporation |
||
[DPM/Lymph Node Pair] |
Stimulation Index(a) |
||
1 |
Vehicle propylene glycol |
418.3 |
1.00 |
2 |
30 % TS in propylene glycol |
973.2 |
1.12 |
|
Lymph Node Weight |
||
[mg/Lymph Node Pair] |
Stimulation Index(a) |
||
1 |
Vehicle propylene glycol |
4.4 |
1.00 |
2 |
30 % TS in propylene glycol |
4.9 |
1.12 |
TS: test substance; (a): test group x / test group 1 (vehicle control) |
Table 2: Ear weight: test group mean values and stimulation indices
Test group |
Treatment |
Ear weight |
|
[Counts/Lymph Node Pair] |
Stimulation Index(a) |
||
1 |
Vehicle propylene glycol |
31.9 |
1.00 |
2 |
30 % TS in propylene glycol |
34.5 |
1.08 |
Table 3: Mean body weight (bw) and body weight changes (bwc)
Test group |
Treatment |
Mean values ± standard deviations |
||
bw at day 0 |
bw at day 5 |
bwc day5-day0 |
||
1 |
Vehicle propylene glycol |
19.7 ± 1.2 |
20.3 ± 0.9 |
0.6 ± 0.5 |
2 |
30 % TS in propylene glycol |
19.8 ± 0.6 |
20.9 ± 0.7 |
1.1 ± 0.7 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.